Page last updated: 2024-08-24

difloxacin and Escherichia coli Infections

difloxacin has been researched along with Escherichia coli Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abo El-Ela, FI; El-Banna, HA; El-Gendy, AA; Radi, AM; Tohamy, MA1
Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC1
Amiridis, GS; Fragkou, IA; Fthenakis, GC; Gougoulis, DA; Mavrogianni, VS1
Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N1

Other Studies

4 other study(ies) available for difloxacin and Escherichia coli Infections

ArticleYear
Pharmacokinetics of difloxacin in healthy and E. coli-infected broiler chickens.
    British poultry science, 2014, Volume: 55, Issue:6

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Escherichia coli Infections; Female; Injections, Intravenous; Male; Microbial Sensitivity Tests; Poultry Diseases

2014
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
    Veterinary microbiology, 2012, Jan-27, Volume: 154, Issue:3-4

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation

2012
Efficacy of difloxacin for the control of postpartum uterine infections of ewes.
    Journal of veterinary pharmacology and therapeutics, 2007, Volume: 30, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Case-Control Studies; Ciprofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Pregnancy; Puerperal Disorders; Sheep; Sheep Diseases; Uterine Diseases

2007
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Immunosuppression Therapy; Klebsiella Infections; Mice; Norfloxacin; Piperazines; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Quinolines; Salmonella Infections, Animal; Staphylococcal Infections; Streptococcal Infections

1986